Mark is a business leader and physician, who brings more than 20 years’ experience in innovation, healthcare and business. He serves on the board of Health Innovation Manchester in addition to being a board advisor to a range of technology start-ups.

His international career spans life sciences, healthcare, and consumer goods sectors and he has held senior leadership positions in Procter and Gamble and Novartis. Most recently, he was the Chief Communications and Patient Officer for Novartis Pharmaceuticals.

Mark is the vice chair and the lead non-executive director for the technology appraisal and highly specialised technologies appeals process.